Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Endur Asa (0JGO)

Endur Asa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0JGO
DateTimeSourceHeadlineSymbolCompany
02/11/201806:19PR Newswire (US)BerGenBio to Present Late-breaking Abstract on Phase II Trial of Bemcentinib in Combination With KEYTRUDA® in Advanced NSCLC...LSE:0JGOEndur Asa
02/11/201806:16PR Newswire (US)BerGenBio to Present Late-breaking Abstract on Phase II Trial of Bemcentinib in Combination With KEYTRUDA® in Advanced NSCLC...LSE:0JGOEndur Asa
 Showing the most relevant articles for your search:LSE:0JGO